PRESS RELEASE published on 07/24/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures plc (GROW) announces transaction in own shares, with 50,000 ordinary shares purchased on 23 July 2025. Highest price: 348.60p, Lowest price: 343.00p Share Repurchase Ordinary Shares Molten Ventures Plc Own Shares Transaction
BRIEF published on 07/23/2025 at 08:05, 1 year 3 months ago Molten Ventures Announces Share Repurchase Share Capital Share Repurchase Financial Regulation Molten Ventures Market Purchase
BRIEF published on 07/23/2025 at 08:05, 1 year 3 months ago Molten Ventures annonce un rachat d'actions Rachat D'actions Réglementation Financière Capital Social Entreprises En Fusion Achat Sur Le Marché
PRESS RELEASE published on 07/23/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announced a transaction in own shares on 22 July 2025 through a share repurchase program. Detailed purchase information provided by Numis Securities Limited Numis Securities Limited Molten Ventures Transaction Details Share Repurchase Program LSE: GROW
BRIEF published on 07/22/2025 at 08:05, 1 year 3 months ago Molten Ventures Announces Share Repurchase Transaction Share Repurchase Stock Buyback Financial Conduct Authority Molten Ventures Deutsche Numis
BRIEF published on 07/22/2025 at 08:05, 1 year 3 months ago Molten Ventures annonce une opération de rachat d'actions Rachat D'actions Autorité De Conduite Financière Deutsche Numis Entreprises En Fusion
PRESS RELEASE published on 07/22/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces the purchase of 23,102 Ordinary Shares on 21/07/2025 by Numis Securities. Share repurchase program details disclosed Share Repurchase Molten Ventures Plc LSE GROW Numis Securities
BRIEF published on 07/21/2025 at 08:05, 1 year 3 months ago Molten Ventures Executes Share Repurchase Share Repurchase Ordinary Shares Numis Securities Molten Ventures Market Regulation
BRIEF published on 07/21/2025 at 08:05, 1 year 3 months ago Molten Ventures procède au rachat d'actions Rachat D'actions Actions Ordinaires Numis Securities Molten Ventures Régulation Du Marché
PRESS RELEASE published on 07/21/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces transaction in own shares through share repurchase program on 18 July 2025. Details of shares purchased and prices disclosed Share Repurchase Ordinary Shares Molten Ventures Plc Transaction LSE: GROW
Published on 11/10/2026 at 14:31, 35 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 36 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:00, 1 hour 6 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 14:55, 11 minutes ago Geely Farizon Launches 2027 Model Year SV in Germany, Bringing Integrated Passenger and Commercial Vehicle Services to Local Customers
Published on 11/10/2026 at 14:46, 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 11/10/2026 at 14:00, 1 hour 6 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 2 au 6 novembre 2026
Published on 11/10/2026 at 14:00, 1 hour 6 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 4 hours 3 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 4 hours 3 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 8 hours 6 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
